These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 32488

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia.
    Diamond BI, Borison RL.
    Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Is there a presynaptic tardive dyskinesia?
    Bowers MB, Glazer WM.
    J Clin Psychopharmacol; 1987 Feb; 7(1):57-9. PubMed ID: 2880877
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The role of cyclic nucleotides in the regulation of neurotransmitter release from adrenergic neurons by neuromodulators.
    Weiner N.
    Essays Neurochem Neuropharmacol; 1980 Feb; 4():69-124. PubMed ID: 6104599
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. An approach to drug abuse, intoxication and withdrawal.
    Giannini AJ.
    Am Fam Physician; 2000 May 01; 61(9):2763-74. PubMed ID: 10821156
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dyskinesia induced by long-term treatment with antipsychotic drugs: involvement of pre- and postsynaptic dopaminergic mechanisms.
    Engel J, Liljequist S, Goldstein M.
    Adv Biochem Psychopharmacol; 1980 May 01; 23():387-95. PubMed ID: 6104913
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The effect of chronic ethanol administration on central neurotransmitter mechanisms.
    Liljequist S, Engel J.
    Med Biol; 1979 Aug 01; 57(4):199-210. PubMed ID: 41985
    [Abstract] [Full Text] [Related]

  • 34. Neurochemistry and behavior in man.
    Omenn GS.
    West J Med; 1976 Dec 01; 125(6):434-51. PubMed ID: 12619
    [Abstract] [Full Text] [Related]

  • 35. Neuropeptides in behavior and psychiatric syndromes: an overview.
    Barchas JD, Elliott GR.
    Res Publ Assoc Res Nerv Ment Dis; 1986 Dec 01; 64():287-307. PubMed ID: 2873638
    [No Abstract] [Full Text] [Related]

  • 36. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Dec 01; 85(2):269-77. PubMed ID: 2858951
    [No Abstract] [Full Text] [Related]

  • 37. The effect of morphine tolerance-dependence and abstinence on mu, delta, and kappa opiate receptors of discrete brain regions and spinal cord of the rat.
    Bhargava HN, Gulati A.
    NIDA Res Monogr; 1990 Dec 01; 105():530-1. PubMed ID: 1652091
    [No Abstract] [Full Text] [Related]

  • 38. [Substance regulation of behavior].
    de Wied D.
    Ned Tijdschr Geneeskd; 1983 Jul 16; 127(29):1284-7. PubMed ID: 6136923
    [No Abstract] [Full Text] [Related]

  • 39. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
    Kristjansen P.
    Adv Biochem Psychopharmacol; 1980 Jul 16; 24():505-11. PubMed ID: 6105796
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.